Stem Cells

HighQC™ Human IPSC From Adipose Mesenchymal Stromal Cells

  • For research use only

Cat No.

ABC-SC0012T

Product Type

Human iPSCs

Cell Type

Induced Pluripotent Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Adipose Mesenchymal Stromal

Disease

Normal

Storage

Liquid Nitrogen

AcceGen offers human iPS cell lines derived from Adipose Mesenchymal Stromal Cells.

Product Image

Description

HighQC™ Human iPSC From Adipose Mesenchymal Stromal Cells is an induced pluripotent stem cell derived from adipose-derived mesenchymal stromal cells (AD-MSCs). The iPS cell line was generated via episomal reprogramming with proprietary vectors encompassing OCT4, SOX2, KLF4, p53 antisense, and EBNA-1. The resulting iPSC lines exhibit typical pluripotent colony morphology, express pluripotency markers such as OCT4, SOX2 and NANOG, exhibit normal and stable genomes, and demonstrate robust trilineage differentiation capacity into the three embryonic germ layers (ectoderm, mesoderm, and endoderm). These iPSCs also maintain a normal and stable karyotype, making them suitable for downstream applications in disease modeling. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.

Product Code

HighQC™ Human IPSC From Adipose Mesenchymal Stromal Cells, Human iPSC-Adip-MSC, hIPSC-Adip-MSC, Human Adipose MSC Derived iPSC

Species

Human

Cat.No

ABC-SC0012T

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Induced Pluripotent Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Adipose Mesenchymal Stromal

Disease

Normal

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Application

  • HighQC™ Human iPSCs From Adipose Mesenchymal Stromal Cells serve as a patient-specific in vitro model to study the pathogenesis of systemic sclerosis, particularly its vascular complications. These iPSCs can be efficiently differentiated into endothelial cells to investigate molecular mechanisms underlying vasculopathy, fibrosis, and immune dysfunction. This enables research into disease mechanisms and provides a platform for personalized therapeutic development, including targeted drug screening and potential gene editing studies for vascular dysfunction in systemic sclerosis.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human IPSC From Adipose Mesenchymal Stromal Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button